Green Cross Lab Cell Corporation (144510) — Capital Reinvestment Ratio
Green Cross Lab Cell Corporation (144510) has a Capital Reinvestment Ratio of 0.09x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩6.67 Billion) in capital expenditures (₩624.50 Million). See 144510 net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Green Cross Lab Cell Corporation Capital Reinvestment Ratio (2015–2024)
This chart tracks Green Cross Lab Cell Corporation's Capital Reinvestment Ratio across 9 annual periods. Check Green Cross Lab Cell Corporation (144510) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Green Cross Lab Cell Corporation (2015–2024)
Year-by-year Capital Reinvestment Ratio for Green Cross Lab Cell Corporation from 2015 to 2024. For live market cap and broader valuation context, see 144510 company net worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.53x | ₩11.34 Billion | ₩6.03 Billion | ▼ -89.4% |
| 2023 | 5.01x | ₩3.67 Billion | ₩18.40 Billion | ▲ +4713.9% |
| 2022 | 0.10x | ₩66.42 Billion | ₩6.91 Billion | ▼ -77.1% |
| 2021 | 0.45x | ₩23.91 Billion | ₩10.88 Billion | ▼ -13.6% |
| 2020 | 0.53x | ₩9.09 Billion | ₩4.79 Billion | ▼ -97.8% |
| 2019 | 23.96x | ₩223.04 Million | ₩5.34 Billion | ▲ +146.1% |
| 2018 | 9.74x | ₩490.92 Million | ₩4.78 Billion | ▲ +1468.4% |
| 2017 | 0.62x | ₩2.86 Billion | ₩1.78 Billion | ▲ +10.8% |
| 2015 | 0.56x | ₩1.49 Billion | ₩833.86 Million | — |